echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Many provinces issue the quality announcement of traditional Chinese Medicine

    Many provinces issue the quality announcement of traditional Chinese Medicine

    • Last Update: 2018-05-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] on May 10, the State Food and Drug Administration issued the notice on 7 batches of drugs not conforming to the regulations (No 22, 2018), 7 batches of drugs were unqualified, including 5 batches of Chinese herbal pieces On the issue of Chinese herbal pieces, both experts and scholars, industry insiders, and media people have put forward remediation suggestions The state has also increased efforts to regulate the quality of Chinese herbal pieces from the policy level But at present, the quality of Chinese herbal pieces is still not optimistic The author learned that from April 11 to May 11, six provinces issued drug quality reports in one month, among which Jiangxi issued the second and third phase notices, and Shandong and Gansu issued two notices In the notice issued by each province, there are many batches of Chinese herbal pieces, and even some drugs that do not meet the requirements are all Chinese Herbal Pieces in the list Hubei: 107 batches of drugs are unqualified, and 85 batches are Chinese herbal pieces On April 11, Hubei food and Drug Administration issued a drug quality announcement (the first issue in 2018) It conducted spot check and inspection on the drug quality of drug production, operation and use units of Hubei Province by food and drug administration at all levels, and found that 107 batches of drugs do not meet the standards In the uploaded attachment, 85 batches of Chinese herbal pieces are included Hubei food and Drug Administration said it would investigate and deal with the drugs and related units that do not meet the standards and regulations according to the provisions of the drug administration law of the people's Republic of China, and report the handling results and relevant information to the provincial administration in a timely manner For the drugs that are verified to be produced by non marked manufacturing enterprises or have no clear purchase channels, trace the source and thoroughly investigate the source of the problem drugs; those suspected of crimes shall be transferred to the public security organ in time for criminal responsibility Sichuan: 26 batches of drugs are unqualified, and 23 batches are Chinese Herbal Pieces In order to strengthen drug supervision and ensure the safety and effectiveness of drug use, in accordance with the notice of the office of Sichuan food and Drug Administration on Issuing the task of drug sampling in 2018 (csyjb [2018] No 71), Sichuan food and drug administration has carried out the sampling inspection of key varieties and daily supervision of drug production, operation and use units On April 13, Sichuan food and Drug Administration issued the drug quality announcement (phase 1, 2018) There were 26 batches of unqualified drugs, of which 23 batches were Chinese herbal pieces The relevant departments will investigate the illegal activities of the production and sale of substandard drugs and related enterprises or units, and publicize the results within three months Shandong issued two announcements: all the substandard drugs were Chinese herbal pieces on April 16 Shandong food and Drug Administration issued the notice on the unqualified quality sampling of 68 batches of Chinese herbal pieces, which said that 68 batches of drugs were substandard, and all of them were Chinese herbal pieces On May 7, Shandong food and Drug Administration issued the notice on unqualified quality sampling of 72 batches of drugs, 72 batches of which were unqualified, 70 of which were Chinese herbal pieces For the above situation, Shandong food and Drug Administration said that for the non-conforming products and the corresponding enterprises and units, the relevant municipal bureaus should strengthen supervision, urge them to find out the causes of the problems, formulate and implement the rectification measures, so as to effectively eliminate the potential risks Gansu issued two announcements: two times of unqualified drugs were all Chinese herbal pieces on April 19, and Gansu food and Drug Administration issued a drug quality announcement 25 batches of drugs were found unqualified, all of them were Chinese herbal pieces On May 4, Gansu Province released the drug quality announcement again, 29 batches of drugs were found to be unqualified, and all of them were pieces of traditional Chinese medicine For the two inspections, Gansu food and drug administration mainly conducted targeted supervision and sampling inspection on the traditional Chinese medicine pieces that did not meet the requirements in previous years in the whole province, with prominent problems of adulteration and adulteration, easy to dye, gain weight and sulfur fumigation On April 27, Jiangxi released the second and third phase drug quality announcements, and Jiangxi food and Drug Administration released the second phase drug quality announcement of Jiangxi Province in 2018 and the third phase drug quality announcement of Jiangxi Province in 2018 In the second phase, 105 batches of drugs were unqualified, and 77 batches of Chinese herbal pieces were unqualified In the third phase, 148 batches of drugs were unqualified, and 97 batches of Chinese herbal pieces were unqualified Hebei: two batches of drugs are unqualified, all of which are Chinese herbal pieces on April 27 The food and Drug Administration of Hebei Province also issued a notice on drug quality (the first phase of drug supervision and sampling inspection in 2018) Two batches of drugs are unqualified, all of which are Chinese herbal pieces Hebei food and Drug Administration said it would investigate the illegal activities of producing and selling unqualified products, and publicize the risk control measures within one week, and publicize the treatment results of enterprises or units that produce and sell unqualified drugs within three months Heilongjiang: 18 batches of drugs are unqualified, and 14 batches are Chinese herbal pieces On May 4, Heilongjiang food and Drug Administration issued the notice on unqualified 18 batches of drugs (preparations) and Chinese herbal pieces (issue 4, 2018) According to the notice, 18 batches of drugs failed to pass the random inspection by 6 inspection institutions including Heilongjiang food and drug inspection and testing institute, 14 of which were Chinese herbal pieces.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.